Rapid Regression of Choroidal Metastasis under First-Line Osimertinib Therapy in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Case Report.
Overview & Synopsis
Open access biomedical research article published in Case Rep Ophthalmol.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Rapid Regression of Choroidal Metastasis under First-Line Osimertinib Therapy in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Case Report. |
|---|---|
| Author / Organization | Hufnagel HJ, Zeitz O, Abdula F, Joussen AM, Zur Bonsen LS |
| Subject & Discipline | Case Rep Ophthalmol |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-50046 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |